Checkpoint Therapeutics
CKPT
CKPT was delisted on the 29th of May, 2025.
62 hedge funds and large institutions have $10.3M invested in Checkpoint Therapeutics in 2022 Q2 according to their latest regulatory filings, with 8 funds opening new positions, 11 increasing their positions, 17 reducing their positions, and 11 closing their positions.
250% more call options, than puts
Call options by funds: $480K | Put options by funds: $137K
0.49% less ownership
Funds ownership: 1.68% → 1.19% (-0.49%)
7% less funds holding
Funds holding: 67 → 62 (-5)
27% less first-time investments, than exits
New positions opened: 8 | Existing positions closed: 11
35% less repeat investments, than reductions
Existing positions increased: 11 | Existing positions reduced: 17
55% less capital invested
Capital invested by funds: $22.8M → $10.3M (-$12.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
GCP
GSA Capital Partners
London,
United Kingdom
|
+$83K |
| 2 |
VF
Virtu Financial
New York
|
+$65.2K |
| 3 |
RJFSA
Raymond James Financial Services Advisors
St. Petersburg,
Florida
|
+$56.1K |
| 4 |
JSMC
Jess S. Morgan & Co
Los Angeles,
California
|
+$55.8K |
| 5 |
BlackRock
New York
|
+$47K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$1.96M |
| 2 |
Norges Bank
Oslo,
Norway
|
-$475K |
| 3 |
Millennium Management
New York
|
-$386K |
| 4 |
Two Sigma Investments
New York
|
-$336K |
| 5 |
Goldman Sachs
New York
|
-$292K |
CKPT Hedge Fund Activity: Q2 2022 in Review
62 of the 5,959 institutional investors tracked by Wall St. Rank reported a position in Checkpoint Therapeutics (CKPT) for Q2 2022, worth a combined $10.3M — down 55% from $22.8M a quarter earlier.
Sellers outnumbered buyers: 11 funds closed out of CKPT and 8 opened new positions — a net loss of 3 holders — while 17 trimmed existing stakes and 11 added.
The largest buyer was GSA Capital Partners, opening a new position worth an estimated $83K. The largest seller was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, exiting entirely with an estimated $1.96M sold.
- 62 institutional investors held Checkpoint Therapeutics (CKPT) as of Q2 2022, down from 67 in Q1 2022.
- Funds reported $10.3M of Checkpoint Therapeutics stock for Q2 2022, down 55% quarter-over-quarter.
- 8 funds opened new Checkpoint Therapeutics positions in Q2 2022 and 11 closed out, a net change of -3 holders.
- The largest Checkpoint Therapeutics buyer in Q2 2022 was GSA Capital Partners, an estimated $83K added.
- The largest Checkpoint Therapeutics seller in Q2 2022 was Healthcare of Ontario Pension Plan (HOOPP) Trust Fund, an estimated $1.96M sold.
Based on aggregated 13F filings for Q2 2022.